TrialJournal for immunotherapy of cancer2026

Prospective study of patients with immune checkpoint inhibitor-induced hepatitis; characterization of liver injury, outcome of therapy, and management of steroid-unresponsive and steroid-dependent hepatitis.

Rikke Boedker Holmstroem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.